A Houston-based medtech startup with an innovative tool that's aiming to transform lung cancer intervention has closed its series A extension round.| InnovationMap
The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have formed a joint venture to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.| InnovationMap
Several prominent cancer researchers are coming to the Houston area thanks to $22 million in grants recently awarded by the Cancer Prevention and Research Institute of Texas (CPRIT).| InnovationMap